ArticleAdvanced materials (Deerfield Beach, Fla.)2026
Thermally Modulated Metasurface Sensor for Dynamic and Time-Resolved Isolation of Extracellular Vesicles.
Article in Advanced materials (Deerfield Beach, Fla.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Extracellular vesicles (EVs) are nanoscale lipid-bilayered structures that mediate intercellular communications by transporting nucleic acids, proteins, and lipids across diverse biological fluids. Their diagnostic potential is immense, yet their heterogeneity poses persistent challenges for isolation and characterization, often leading to low yield, co-isolation of contaminants, and vesicle damage. Here, we present a thermoresponsive polymer-integrated plasmonic metasurface sensor that enables spatiotemporally controlled, label-free EV isolation. The metasurface, engineered by repurposing nanograted optical disks, was functionalized with poly(N-isopropylacrylamide) (PNIPAM) and anti-CD63 antibodies to achieve selective EV capture at physiological temperature and gentle release upon a minute thermal change near the polymer's lower critical solution temperature (∼35°C). Using MCF-7 and HEK-293-derived EVs as a proof-of-concept, the platform exhibited a dynamic detection range spanning three orders of magnitude. Release efficiency reached 87.03 ± 23.5%, while both nanoparticle tracking analysis (NTA) and fluorescent NTA (fNTA) revealed up to ∼100-fold increase in EV purity relative to the ultrafiltration process. Electron microscopy and Western blotting confirmed preserved vesicle morphology and marker expression. By integrating thermoresponsive chemistry with a cost-effective metasurface platform, this system offers a non-destructive, portable, and real-time solution for precise EV manipulation, advancing EV-focused biosensing and point-of-care strategies for liquid biopsy applications in the future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.